Garantie de satisfaction à 100% Disponible immédiatement après paiement En ligne et en PDF Tu n'es attaché à rien
logo-home
Complete Test Bank Claytons Basic Pharmacology for Nurses 19th Edition Willihnganz Questions & Answers with rationales (Chapter 1-48) GRADED A €14,46   Ajouter au panier

Examen

Complete Test Bank Claytons Basic Pharmacology for Nurses 19th Edition Willihnganz Questions & Answers with rationales (Chapter 1-48) GRADED A

1 vérifier
 174 vues  17 fois vendu
  • Cours
  • Nursing pharmacology
  • Établissement
  • Nursing Pharmacology

Complete Test Bank Claytons Basic Pharmacology for Nurses 19th Edition Willihnganz Questions & Answers with rationales (Chapter 1-48) GRADED A Complete Test Bank Claytons Basic Pharmacology for Nurses 19th Edition Willihnganz Questions & Answers with rationales (Chapter 1-48) GRADED A

Aperçu 4 sur 405  pages

  • 9 août 2023
  • 405
  • 2023/2024
  • Examen
  • Questions et réponses
  • Nursing pharmacology
  • Nursing pharmacology

1  vérifier

review-writer-avatar

Par: perfectstudies001 • 8 mois de cela

avatar-seller
Test Bank For Clayton’s Basic Pharmacology for Nurses 19th Edition 1 Chapter 01: Drug Definitions, Standards, and Information Sources Willihnganz: Clayton’s Basic Pharmacology for Nurses, 19th Edition MULTIPLE CHOICE 1. Which name identifies a drug listed by the US Food and Drug Administration (FDA)? a. Brand b. Nonproprietary c. Official d. Trademark ANS: C The official name is the name under which a drug is listed by the FDA. The brand name, or trademark, is the name given to a drug by its manufacturer. The nonproprietary, or generic, name is provided by the United States Adopted Names Council. DIF: Cognitive Level: Knowledge REF: p. 9 OBJ: 1 NAT: NCLEX Client Needs Category: Safe, Effective Care Environment TOP: Nursing Process Step: Assessment CON: Patient Education 2. Which source contains information specific to nutritional supplements? a. USP Dictionary of USAN & International Drug Names b. Natural Medicines Comprehensive Database c. United States Pharmacopoeia/National Formulary (USP NF) d. Drug Interaction Facts ANS: C United States Pharmacopoeia/National Formula ry contains information specific to nutritional supplements. USP Dictionary of USAN & International Drug Names is a compilation of drug names, pronunciation guide, and possible future FDA approved drugs; it does not include nutritional supplements. Natural Medicines Comprehensive Database contains evidence -based information on herbal medicines and herbal combination products; it does not include information specific to nutritional supplements. Drug Interaction Facts contains comprehensive information on dru g interaction facts; it does not include nutritional supplements. DIF: Cognitive Level: Knowledge REF: p. 4 OBJ: 3 NAT: NCLEX Client Needs Category: Physiological Integrity TOP: Nursing Process Step: Assessment CON: Nutrition | Patient Education 3. Which drug reference contains drug monographs that describe all drugs in a therapeutic class? a. Drug Facts and Comparisons Test Bank For Clayton’s Basic Pharmacology for Nurses 19th Edition 2 b. Drug Interaction Facts c. Handbook on Injectable Drugs d. Martindale —The Complete Drug Reference ANS: A Drug Facts and Comparisons contains drug mon ographs that describe all drugs in a therapeutic class. Monographs are formatted as tables to allow comparison of similar products, brand names, manufacturers, cost indices, and available dosage forms Online version is available. DIF: Cognitive Level: Knowledge REF: p. 4 Table 1.2 OBJ: 3 NAT: NCLEX Client Needs Category: Physiological Integrity TOP: Nursing Process Step: Assessment CON: Safety | Patient Education | Clinical Judgment 4. Which drug reference contains monographs about virtually every single -entity drug available in the United States and describes therapeutic uses of drugs, including approved and unapproved uses? a. Martindale: The Complete Drug Reference b. AHFS Drug Information c. Drug Reference d. Drug Facts and Comparisons ANS: B AHFS Drug Information contains monographs about virtually every single -entity drug available in the United States and describes therapeutic uses of drugs, including approved and unapproved uses. DIF: Cognitive Level: Knowledge REF: p. 4 Table 1.2 OBJ: 3 NAT: NCLEX Client Needs Category: Physiological Integrity TOP: Nursing Process Step: Planning CON: Safety | Patient Education | Clinical Judgment 5. Which online drug reference makes available to healthcare providers and the public a standard, comprehensive, up-to-date look up and downloadable resource about medicines? a. American Drug Index b. American Hospital Formulary c. DailyMed d. Drug Reference ANS: C DailyMed makes available to healthcare providers and the public a standard, comprehensive, up-to-date look up and downloadable resource about medicines. The American Drug Index is not appropriate for patient use. The American Hospital Formulary is not appropriate for patient use. The drug reference is not appropriate for patient use. DIF: Cognitive Level: Knowledge REF: p. 3 | p. 4 OBJ: 3 NAT: NCLEX Client Needs Category: Physiological Integrity TOP: Nursing Process Step: Implementation CON: Safety | Patient Education | Clinical Judgment 6. Which legislation authorizes the FDA to determine the safety of a drug before its marketing? a. Federal Food, Drug, and Cosmetic Act (1938) b. Durham Humphrey Amendment (1952) Test Bank For Clayton’s Basic Pharmacology for Nurses 19th Edition 3 c. Controlled Substances Act (1970) d. Kefauver Harris Drug Amendment (1962) ANS: A The Federal Food, Drug, and Cosmetic Act of 1938 authorized the FDA to determine the safety of all drugs bef ore marketing. Later amendments and acts helped tighten FDA control and ensure drug safety. The Durham Humphrey Amendment defines the kinds of drugs that cannot be used safely without medical supervision and restricts their sale to prescription by a licens ed practitioner. The Controlled Substances Act addresses only controlled substances and their categorization. The Kefauver Harris Drug Amendment ensures drug efficacy and greater drug safety. Drug manufacturers are required to prove to the FDA the effectiv eness of their products before marketing them. DIF: Cognitive Level: Knowledge REF: p. 5 Table l.3 OBJ: 5 NAT: NCLEX Client Needs Category: Physiological Integrity TOP: Nursing Process Step: Assessment CON: Safety | Patient Education | Evidence | Health Care Law 7. Which classification does meperidine (Demerol) fall under? a. I b. II c. III d. IV ANS: B Meperidine (Demerol) is a Schedule II drug; it has a high potential for abuse and may lead to severe psychological and physical dependence. Schedule I drugs have high potential for abuse and no recognized medical use. Schedule III drugs have some potential for abuse. Use may lead to low to moderate physical dependence or high psychological dependence. Schedule IV drugs have low potential for abuse. Use may lead to limited physical or psychological dependence. DIF: Cognitive Level: Knowledge REF: p. 10 OBJ: 2 NAT: NCLEX Client Needs Category: Safe, Effective Care Environment TOP: Nursing Process Step: Assessment CON: Patient Education | Addiction | Pain 8. Which action would the FDA take to expedite drug development and approval for an outbreak of smallpox? a. List smallpox as a health orphan disease. b. Omit the preclinical research phase. c. Extend the clinical research phase. d. Fast track the investigational drug. ANS: D Once the Inv estigational New Drug Application has been approved, the drug can receive highest priority within the agency, which is called fast tracking. A smallpox outbreak would become a priority concern in the world. Orphan diseases are not researched in a priority manner. Preclinical research is not omitted. Extending any phase of the research would mean a longer time to develop a vaccine. The FDA must ensure that all phases of the preclinical and clinical research phase have been completed in a safe manner. DIF: Cognitive Level: Knowledge REF: p. 7 OBJ: 5 Test Bank For Clayton’s Basic Pharmacology for Nurses 19th Edition 4 NAT: NCLEX Client Needs Category: Safe, Effective Care Environment TOP: Nursing Process Step: Assessment CON: Health Care Law | Health Care Policy | Infection | Care Coordination 9. Which statement is true about over-the-counter (OTC) drugs? a. They are not listed in the USP NF. b. A prescription from a healthcare provider is needed. c. They are sold without a prescription. d. They are known only by their brand names. ANS: C OTC medications do not require a prescription. A vari ety of names, both generic and trade, can be used for individual drugs sold OTC. OTC drugs are listed in the USP NF. Prescription drugs require an order by a health professional who is licensed to prescribe, such as a physician, nurse practitioner, physici an assistant, or dentist. DIF: Cognitive Level: Comprehension REF: p. 2 OBJ: 2 NAT: NCLEX Client Needs Category: Physiological Integrity TOP: Nursing Process Step: Planning CON: Patient Education 10. Which is the most authoritative reference for medications that are injected? a. Martindale: The Complete b. Handbook on Injectable Drugs c. DailyMed d. Handbook of Nonprescription Drugs ANS: B The Handbook on Injectable Drugs is the most comprehensive reference available on the topic of compatibility of injectable drugs. It is a collection of monographs for more than 300 injectable drugs that are listed alphabetically by generic name. DIF: Cognitive Level: Knowledge REF: p. 4 OBJ: 3 NAT: NCLEX Client Needs Category: Physiological Integrity TOP: Nursing Process Step: Assessme nt CON: Clinical Judgment | Safety 11. Which statement is true about Lomotil? a. Abuse potential for this drug is low. b. Psychological dependency is likely. c. There is a high potential for abuse. d. This drug is not a controlled substance. ANS: A Lomotil, a Schedule V drug, has an abuse potential of limited physical or psychological dependence liability compared with drugs in Schedule IV. Because abuse potential is low with a Schedule V drug, a prescription may not be required. Psychological dependency is not likely with a Schedule V drug. Schedule V drugs are classified as controlled substances. DIF: Cognitive Level: Knowledge REF: p. 5 Box 1.1 OBJ: 2 NAT: NCLEX Client Needs Category: Physiological Integrity TOP: Nursing Process Step: Assessment CON: Clinical Judgment | Safety | Patient Education

Les avantages d'acheter des résumés chez Stuvia:

Qualité garantie par les avis des clients

Qualité garantie par les avis des clients

Les clients de Stuvia ont évalués plus de 700 000 résumés. C'est comme ça que vous savez que vous achetez les meilleurs documents.

L’achat facile et rapide

L’achat facile et rapide

Vous pouvez payer rapidement avec iDeal, carte de crédit ou Stuvia-crédit pour les résumés. Il n'y a pas d'adhésion nécessaire.

Focus sur l’essentiel

Focus sur l’essentiel

Vos camarades écrivent eux-mêmes les notes d’étude, c’est pourquoi les documents sont toujours fiables et à jour. Cela garantit que vous arrivez rapidement au coeur du matériel.

Foire aux questions

Qu'est-ce que j'obtiens en achetant ce document ?

Vous obtenez un PDF, disponible immédiatement après votre achat. Le document acheté est accessible à tout moment, n'importe où et indéfiniment via votre profil.

Garantie de remboursement : comment ça marche ?

Notre garantie de satisfaction garantit que vous trouverez toujours un document d'étude qui vous convient. Vous remplissez un formulaire et notre équipe du service client s'occupe du reste.

Auprès de qui est-ce que j'achète ce résumé ?

Stuvia est une place de marché. Alors, vous n'achetez donc pas ce document chez nous, mais auprès du vendeur achievers01. Stuvia facilite les paiements au vendeur.

Est-ce que j'aurai un abonnement?

Non, vous n'achetez ce résumé que pour €14,46. Vous n'êtes lié à rien après votre achat.

Peut-on faire confiance à Stuvia ?

4.6 étoiles sur Google & Trustpilot (+1000 avis)

78629 résumés ont été vendus ces 30 derniers jours

Fondée en 2010, la référence pour acheter des résumés depuis déjà 14 ans

Commencez à vendre!
€14,46  17x  vendu
  • (1)
  Ajouter